Patents Assigned to Phoenix Pharmacologies, Inc.
  • Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same
    Patent number: 6645739
    Abstract: The present invention provides novel expression systems for producing desired polypeptides in certain strains of yeast. The present invention further provides methods for producing polypeptide products using such expression systems. The present invention also provides compositions relating to the same.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: November 11, 2003
    Assignee: Phoenix Pharmacologies, Inc.
    Inventor: Mike A. Clark
  • Mutated form of arginine deiminase
    Patent number: 6635462
    Abstract: The present invention discloses arginine deiminase that is genetically modified for more efficient manufacturing and processing. The present invention discloses recombinant DNA molecules and vectors and other therapeutic and pharmaceutical compositions. The present invention also discloses methods for preparing modified arginine deiminase as well as methods of treating cancer and other disease states using modified arginine deiminase.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: October 21, 2003
    Assignee: Phoenix Pharmacologies, Inc.
    Inventors: Charles Mark Ensor, Frederick Wayne Holtsberg, Mike A. Clark